Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Melanoma 2Lung Neoplasms 2Hematologic Neoplasms 2Advanced Malignant Solid Neoplasm 2Urinary Bladder Neoplasms 1Spondylitis, Ankylosing 1Signs and Symptoms 1Rectal Neoplasms 1Psoriasis 1Ovarian Neoplasms 1Neoplasm Metastasis 1Malignant Solid Neoplasm 1Malignant Female Reproductive System Neoplasm 1Lymphedema 1Lupus Erythematosus, Systemic 1Kidney Neoplasms 1Inflammatory Breast Neoplasms 1Inflammatory Bowel Diseases 1Endometrial Neoplasms 1Crohn Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1Colitis, Ulcerative 1Carcinoma, Renal Cell 1Autoimmune Diseases 1Arthritis, Rheumatoid 1

Interventions

Bevacizumab 19Paclitaxel 17Carboplatin 12pembrolizumab 11liposomal doxorubicin 10Gemcitabine 9Cyclophosphamide 9Topotecan 8Specimen Handling 8olaparib 7fludarabine 7Magnetic Resonance Spectroscopy 7Taxes 5Immunoglobulin G 5Fulvestrant 5Disulfides 5niraparib 4Oxaliplatin 4Nivolumab 4Biopsy 4trastuzumab deruxtecan 3palbociclib 3mirvetuximab soravtansine 3aldesleukin 3Leucovorin 3Fluorouracil 3Doxorubicin 31-dodecylpyridoxal 3ulixertinib 2nilotinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ovarian Neoplasms × Methods × 30 days × Clear all
NCT05056077 2026-06-02

TTBF

University of California, San Francisco

Phase NA Active not recruiting
353 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡